Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.390
-0.050 (-3.47%)
At close: Sep 4, 2026, 4:00 PM EDT
1.380
-0.010 (-0.72%)
After-hours: Sep 4, 2026, 7:25 PM EDT
Enveric Biosciences Market Cap
Enveric Biosciences has a market cap or net worth of $6.22 million as of September 4, 2026. Its market cap has increased by 82.52% in one year.
Market Cap
6.22M
Enterprise Value
-2.07M
1-Year Change
82.52%
Ranking
Category
Stock Price
$1.39
ChartMarket Cap Chart
Since December 31, 2020, Enveric Biosciences's market cap has decreased from $135.21B to $6.22M, a decrease of -100.00%. That is a compound annual growth rate of -82.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 6.22M | 67.48% |
| Dec 31, 2025 | 3.71M | 1.92% |
| Dec 31, 2024 | 3.64M | 20.78% |
| Dec 29, 2023 | 3.02M | -30.19% |
| Dec 30, 2022 | 4.32M | -85.19% |
| Dec 31, 2021 | 29.19M | -99.98% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ernexa Therapeutics | 7.04M |
| AIM ImmunoTech | 6.93M |
| CollPlant Biotechnologies | 6.71M |
| GRI Bio | 6.30M |
| Kairos Pharma | 6.23M |
| Purple Biotech | 6.19M |
| NuCana | 6.03M |
| XTL Biopharmaceuticals | 5.88M |